Reversible Cytotoxic Lesion of the Corpus Callosum and COVID-19

Abstract

Keywords

COVID-19 corpus callosum magnetic resonance imaging

Get full access to this article

View all access options for this article.

References

Tetsuka

. Reversible lesion in the splenium of the corpus callosum. Brain Behav. 2019;9(11):e01440. doi:10.1002/brb3.1440

Moreau

Ego

Vandergheynst

, et al. Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection. J Neurol. 2021;268(5):1592-1594. doi:10.1007/s00415-020-10164-3

Edjlali

le Gal

Louvet

, et al. Teaching NeuroImages: cytotoxic lesions of the corpus callosum in encephalopathic patients with COVID-19. Neurology. 2020;95(22):1021-1022. doi:10.1212/WNL.0000000000010880

Gaur

Dixon

Jones

Lyall

Jan

. COVID-19-associated cytotoxic lesions of the corpus callosum. Am J Neuroradiol. 2020;41(10):1905-1907. doi:10.3174/ajnr.A6713

Starkey

Kobayashi

Numaguchi

Moritani

. Cytotoxic lesions of the corpus callosum that show restricted diffusion: Mechanisms, causes, and manifestations. Radiographics. 2017;37(2):562-576. doi:10.1148/rg.2017160085

Wang

Jiang

Chen

Montaner

. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108(1):17-41. doi:10.1002/JLB.3COVR0520-272R